Dietary and pharmacologic therapy for the lipid risk factors. Severe liver injury, including fatal liver failure, has been reported in some patients. 145. Grundy SM. 174. Tell your doctor if you or anyone in your home has ever had a positive reaction to a tuberculosis test.Using leflunomide may increase your risk of getting serious infections or cancer. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia. Call your doctor for medical advice about side effects. Bilheimer DW. Stop using leflunomide and check with your doctor right away if you have any of the following symptoms while taking leflunomide: blistering, peeling, or loosening of the skin; chills; itching; joint or muscle pain; red skin lesions, often with a purple center; sores, ulcers, or white spots in the mouth or on the lips; or unusual tiredness or weakness.Liver problems may occur while you are using leflunomide. Check with your health care provider before you start, stop, or change the dose of any medicine.Use Carboplatin as directed by your doctor. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. 119. 132. 122. Other side effects not listed may also occur in some patients. Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Men taking leflunomide should use condoms as a form of birth control during sexual intercourse. St. Louis: JB Lippincott Co; 1985(Jan):110a.136. 128. 126. Summary and recommendations of the Conference on Blood Lipids in Children: optimal levels for early prevention of coronary artery disease. You may report side effects to the FDA at 1-800-FDA-1088. Therapy of familial and acquired hyperlipoproteinemia in children and adolescents. CellCept Suspension is used in combination with other medicines. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of high Blood Cholesterol in Adults (Adult Treatment Panel III). Thompson GR, Miller JP, Breslow JL. Briggs GG, Freeman RK, Yaffe SJ. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. Live virus vaccines should not be given while receiving leflunomide.You will need to have your blood pressure measured before starting leflunomide and while you are using it. 6th ed. Kane JP, Malloy MJ, Tun P et al. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Bilheimer DW, Goldstein JL, Grundy SM et al. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. Call your doctor for medical advice about side effects. Tsang RC, Roginsky MS, Mellies MJ et al. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol. 152. Diagnosis and treatment of primary hyperlipidemia in childhood: a joint statement for physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council of Cardiovascular Disease in the Young and the Nutrition Committee. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin. Brown MS, Goldstein JL. Do not store in the bathroom. Thompson GR, Ford J, Jenkinson M et al. This is a decision you and your doctor will make. 142. Call your doctor for medical advice about side effects. 143. 161. Ask your health care provider if CellCept Suspension may interact with other medicines that you take. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.Pregnancy must be excluded before the start of treatment with leflunomide.